Thymosins in multiple sclerosis and its experimental models: moving from basic to clinical application

Background: Multiple sclerosis (MS) afflicts more than 2.5 million individuals worldwide and this number is increasing over time. Within the past years, a great number of disease-modifying treatments have emerged; however, efficacious treatments and a cure for MS await discovery. Thymosins, soluble...

Descripción completa

Detalles Bibliográficos
Autores principales: Severa, Martina, Zhang, Jing, Giacomini, Elena, Rizzo, Fabiana, Etna, Marilena Paola, Cruciani, Melania, Garaci, Enrico, Chopp, Michael, Coccia, Eliana Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2019
Materias:
Review article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104151/
https://www.ncbi.nlm.nih.gov/pubmed/30317071
http://dx.doi.org/10.1016/j.msard.2018.09.035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104151/
https://www.ncbi.nlm.nih.gov/pubmed/30317071
http://dx.doi.org/10.1016/j.msard.2018.09.035

Ejemplares similares